Search

Your search keyword '"Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects"' showing total 66 results

Search Constraints

Start Over You searched for: Descriptor "Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects" Remove constraint Descriptor: "Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects" Journal new england journal of medicine Remove constraint Journal: new england journal of medicine
66 results on '"Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects"'

Search Results

1. Pitavastatin and Cardiovascular Disease in HIV.

4. Pitavastatin and Cardiovascular Disease in HIV.

5. Pitavastatin and Cardiovascular Disease in HIV.

11. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.

12. Polypill Strategy in Secondary Cardiovascular Prevention.

13. N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects.

14. Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and Dysphagia.

15. ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.

16. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

17. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

18. Perioperative Rosuvastatin in Cardiac Surgery.

19. Statin-Associated Autoimmune Myopathy.

20. Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy.

21. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

22. Case records of the Massachusetts General Hospital. Case 14-2015. A 58-year-old woman with shortness of breath.

23. Case records of the Massachusetts General Hospital. Case 38-2014. An 87-year-old man with sore throat, hoarseness, fatigue, and dyspnea.

24. Simvastatin in the acute respiratory distress syndrome.

25. Rosuvastatin for sepsis-associated acute respiratory distress syndrome.

26. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.

28. Statins: is it really time to reassess benefits and risks?

29. Case records of the Massachusetts General Hospital. Case 7-2012. A 79-year-old man with pain and weakness in the legs.

30. Needed: pragmatic clinical trials for statin-intolerant patients.

31. Effect of two intensive statin regimens on progression of coronary disease.

32. Neuromuscular symptoms and elevated creatine kinase after statin withdrawal.

33. Fluvastatin and perioperative events in patients undergoing vascular surgery.

34. A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

35. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

36. Rosuvastatin in patients with elevated C-reactive protein.

37. Rosuvastatin in patients with elevated C-reactive protein.

38. SLCO1B1 variants and statin-induced myopathy.

39. Monoclonal antibody therapy and non-Hodgkin's lymphoma.

40. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

41. Pharmacogenomics and drug toxicity.

42. SLCO1B1 variants and statin-induced myopathy--a genomewide study.

43. Over-the-counter sales of statins and other drugs for asymptomatic conditions.

44. Long-term follow-up of the West of Scotland Coronary Prevention Study.

45. Gynecomastia.

46. Rosuvastatin in older patients with systolic heart failure.

47. Statins and the effect of BCG on bladder cancer.

48. Statins and the effect of BCG on bladder cancer.

49. Use of statins and outcome of BCG treatment for bladder cancer.

50. Statin therapy after stroke or transient ischemic attack.

Catalog

Books, media, physical & digital resources